Intech Investment Management LLC Increases Stock Position in The Clorox Company (NYSE:CLX)

Intech Investment Management LLC lifted its stake in The Clorox Company (NYSE:CLX) by 14.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,370 shares of the company’s stock after acquiring an additional 3,615 shares during the quarter. Intech Investment Management LLC’s holdings in Clorox were worth $4,622,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in CLX. Prospera Private Wealth LLC purchased a new position in shares of Clorox during the 3rd quarter worth $27,000. Innealta Capital LLC bought a new stake in Clorox during the second quarter valued at about $30,000. Trifecta Capital Advisors LLC lifted its holdings in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares in the last quarter. Family Firm Inc. bought a new position in shares of Clorox during the second quarter worth $31,000. Finally, Quarry LP grew its position in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Up 0.1 %

Shares of NYSE:CLX opened at $169.31 on Friday. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.35. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The business has a fifty day moving average of $162.78 and a two-hundred day moving average of $148.43. The stock has a market cap of $20.96 billion, a P/E ratio of 58.99, a PEG ratio of 3.11 and a beta of 0.41.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s revenue was up 27.0% compared to the same quarter last year. During the same period last year, the business earned $0.49 earnings per share. On average, research analysts expect that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is 170.03%.

Insider Activity at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 11.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.57% of the stock is owned by insiders.

Analysts Set New Price Targets

CLX has been the subject of a number of analyst reports. BNP Paribas raised shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. DA Davidson upped their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft raised their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, Citigroup raised their price objective on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.